Henry Schein, Inc.

Henry Schein is a healthcare products and services company that supplies office-based dental and medical practitioners globally. Its operations are organized into three segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The distribution segment offers a wide range of consumable products including infection-control items, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, X-ray supplies, and digital restoration equipment. It also provides equipment repair, financial services, continuing education, and consulting. The specialty products segment manufactures and sells dental implants, biomaterials, endodontic, orthodontic, and orthopedic products. The technology segment develops practice management software, e-services, and related products for healthcare providers.

Henry Schein is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol HSIC. The company's financial reporting is in US Dollars (USD), reflecting its headquarters and primary operations in the United States. As a US-based company trading on a major US exchange, its stock is priced and traded in USD, making it accessible to investors through most brokerage platforms that trade US equities.

Henry Schein operates in the Healthcare sector, specifically within the Medical Distribution industry. This means the company acts as a distributor of medical and dental products to healthcare professionals, rather than manufacturing all products itself. The Medical Distribution industry involves sourcing a vast array of supplies—from pharmaceuticals to equipment—and delivering them to practitioners, clinics, and hospitals. Henry Schein's focus on office-based dental and medical practices distinguishes it from distributors that serve larger hospital systems. Its industry classification reflects its role as a critical link between manufacturers and end-users in the healthcare supply chain.

Henry Schein serves customers globally, with a particular focus on office-based dental and medical practitioners. While the company is headquartered in the United States and its primary exchange is NasdaqGS, its distribution network extends internationally. The company's description indicates it provides products and services to practitioners worldwide, including dental practices, laboratories, physician practices, ambulatory surgery centers, government institutions, and home health providers. Although specific country breakdowns are not provided, the global scope implies operations across North America, Europe, and other regions. The company's Global Distribution and Value-Added Services segment likely handles international logistics, while its Global Specialty Products and Technology segments also have a worldwide reach.

Henry Schein generates revenue through three main business segments. The Global Distribution and Value-Added Services segment is the core, distributing consumable merchandise—including its own corporate brand products—and providing services like equipment repair, financing, and continuing education. This segment sells infection control items, pharmaceuticals, vaccines, dental chairs, X-ray supplies, and more. The Global Specialty Products segment earns revenue by manufacturing and selling dental implants, biomaterials, endodontic, orthodontic, and orthopedic products. The Global Technology segment develops and distributes practice management software, e-services, and related technology to healthcare providers. By offering a comprehensive portfolio of products and value-added services, Henry Schein captures recurring revenue from consumables and one-time sales of equipment and software, serving a diverse customer base of dental and medical practitioners.